MabVax Therapeutics (Nasdaq: MBVX) is a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical development of products to address unmet medical needs in the treatment of cancer. Our antibody MVT-5873, is a fully human IgG1 monoclonal antibody (mAb) that targets sialyl Lewis A (sLea), an epitope on CA19-9, and is currently in Phase 1 clinical trials as a therapeutic agent for patients with pancreatic cancer and other CA19-9 positive tumors. With our collaborators including Memorial Sloan Kettering Cancer Center, Rockefeller University, Sarah Cannon Research Institute, Honor Health and Imaging Endpoints, we have treated 50 patients with either our therapeutic antibody designated as MVT-5873 or our PET imaging diagnostic product designated as MVT-2163 in Phase 1 clinical studies, and demonstrated early safety, specificity for the target and a potential efficacy signal. Patient dosing has commenced for our lead development program in Phase 1 clinical study of the Company's radioimmunotherapy product MVT-1075.
View Top Employees from MabVax Therapeutics, Inc.Website | http://mabvax.com/ |
Ticker | MBVX |
Revenue | $1.3 million |
Funding | $48.3 million |
Employees | 5 (5 on RocketReach) |
Founded | 2006 |
Address | 11535 Sorrento Valley Road Suite 400, San Diego, California 92121, US |
Phone | (858) 259-9405 |
Technologies | |
Industry | Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Medical, Health Care, Pharmaceutical |
Web Rank | 15 Million |
Keywords | Mabvax |
Competitors | Amgen, Immunomedics, Juno Therapeutics, Inc., NexImmune, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 54 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 5417 Companies |
Looking for a particular MabVax Therapeutics, Inc. employee's phone or email?
The MabVax Therapeutics, Inc. annual revenue was $1.3 million in 2024.
5 people are employed at MabVax Therapeutics, Inc..
MabVax Therapeutics, Inc. is based in San Diego, California.
The NAICS codes for MabVax Therapeutics, Inc. are [32, 54, 3254, 541, 325, 32541, 5417].
The SIC codes for MabVax Therapeutics, Inc. are [28, 283].